Predicting sPTB Early: What Do We Do Now?

Article

The objective if this discussion is to look at some of the implications of having an objective predictor. What do we do differently? In what ways can this make a greater difference in our fight against preterm birth? We also need to address some of the uncertainties that exist when we know a woman is at risk for preterm birth.

Predicting sPTB Early: What Do We Do Now?


With the tools available to us today, physicians are unable to predict the large majority of women who will eventually deliver preterm. Now we have a proteomic predictor – which also provides the beginning of greater understanding of pathways.
 
The objective if this discussion is to look at some of the implications of having an objective predictor. What do we do differently? In what ways can this make a greater difference in our fight against preterm birth? We also need to address some of the uncertainties that exist when we know a woman is at risk for preterm birth.
 

 

 

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
Related Content
© 2024 MJH Life Sciences

All rights reserved.